Literature DB >> 16318899

Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?

Vaibhav A Diwadkar1, Debra M Montrose, Diana Dworakowski, John A Sweeney, Matcheri S Keshavan.   

Abstract

Biomarkers proposed in the schizophrenia diathesis have included neurocognitive deficits in domains such as working memory that implicate prefrontal systems. However, the relationship between these biomarkers and psychopathological markers such as schizotypy has not been systematically assessed, particularly in adolescent offspring of schizophrenia patients. Convergence between these markers may identify individuals at especially high risk for schizophrenia. In the current study the authors assessed whether functional deficits in working memory assessed using the oculomotor delayed response task (ODR) and executive function assessed using the Wisconsin Card Sort task (WCST), and structural deficits in prefrontal cortex, in the adolescent offspring of patients were predictive of schizotypy. Schizotypal offspring made more perseverative errors on the WCST (p<.002) and showed age-related deficits on the ODR task (p<.02) compared to their non-schizotypal counterparts or healthy controls. Reduced gray matter concentration in prefrontal cortex (p<.001) was also associated with schizotypy. Schizotypy in offspring of schizophrenia patients appears to be highly associated with known biomarkers of the illness such as executive function impairment and reductions in cortical gray matter. Furthermore, schizotypy appears to interact with development leading to greater impairment in working memory in schizotypal offspring closer to the typical age of onset of schizophrenia than non-schizotypal offspring. Thus, clinical and neurocognitive biomarkers of the illness appear to be highly interrelated in this sample of at-risk offspring. We propose that schizotypy may define a hyper vulnerable sub-sample among individuals genetically predisposed to schizophrenia and that future studies that attempt to assess risk may benefit from such a convergent approach.

Entities:  

Mesh:

Year:  2005        PMID: 16318899     DOI: 10.1016/j.pnpbp.2005.10.019

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  30 in total

1.  Hypo-activation in the executive core of the sustained attention network in adolescent offspring of schizophrenia patients mediated by premorbid functional deficits.

Authors:  Vaibhav A Diwadkar; Jamie Segel; Patrick Pruitt; Eric R Murphy; Matcheri S Keshavan; Jacqueline Radwan; Usha Rajan; Caroline Zajac-Benitez
Journal:  Psychiatry Res       Date:  2011-04-15       Impact factor: 3.222

Review 2.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Authors:  Konasale M Prasad; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

3.  Fronto-parietal hypo-activation during working memory independent of structural abnormalities: conjoint fMRI and sMRI analyses in adolescent offspring of schizophrenia patients.

Authors:  Vaibhav A Diwadkar; Patrick Pruitt; Dhruman Goradia; Eric Murphy; Neil Bakshi; Matcheri S Keshavan; Usha Rajan; Andrew Reid; Caroline Zajac-Benitez
Journal:  Neuroimage       Date:  2011-06-29       Impact factor: 6.556

Review 4.  Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings.

Authors:  Benjamin K Brent; Heidi W Thermenos; Matcheri S Keshavan; Larry J Seidman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-07-23

5.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

6.  Grey matter and cognitive deficits in young relatives of schizophrenia patients.

Authors:  Tejas S Bhojraj; Alan N Francis; Debra M Montrose; Matcheri S Keshavan
Journal:  Neuroimage       Date:  2010-03-31       Impact factor: 6.556

7.  Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study.

Authors:  Yaling Yang; Keith H Nuechterlein; Owen R Phillips; Boris Gutman; Florian Kurth; Ivo Dinov; Paul M Thompson; Robert F Asarnow; Arthur W Toga; Katherine L Narr
Journal:  Hum Brain Mapp       Date:  2012-09       Impact factor: 5.038

8.  An fMRI study of working memory in first-degree unaffected relatives of schizophrenia patients.

Authors:  Shashwath A Meda; Manish Bhattarai; Nicholas A Morris; Robert S Astur; Vince D Calhoun; Daniel H Mathalon; Kent A Kiehl; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2008-08-03       Impact factor: 4.939

9.  Premorbid cognitive deficits in young relatives of schizophrenia patients.

Authors:  Matcheri S Keshavan; Shreedhar Kulkarni; Tejas Bhojraj; Alan Francis; Vaibhav Diwadkar; Debra M Montrose; Larry J Seidman; John Sweeney
Journal:  Front Hum Neurosci       Date:  2010-03-09       Impact factor: 3.169

10.  Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients.

Authors:  Erin A Hazlett; Monte S Buchsbaum; M Mehmet Haznedar; Randall Newmark; Kim E Goldstein; Yuliya Zelmanova; Cathryn F Glanton; Yuliya Torosjan; Antonia S New; Jennifer N Lo; Vivian Mitropoulou; Larry J Siever
Journal:  Schizophr Res       Date:  2008-02-13       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.